Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;55(1):54-61.
doi: 10.1136/bjsports-2020-102789. Epub 2020 Oct 5.

Is extensive cardiopulmonary screening useful in athletes with previous asymptomatic or mild SARS-CoV-2 infection?

Affiliations

Is extensive cardiopulmonary screening useful in athletes with previous asymptomatic or mild SARS-CoV-2 infection?

Salvatore Francesco Gervasi et al. Br J Sports Med. 2021 Jan.

Abstract

Objective: During the COVID-19 pandemic, it is essential to understand if and how to screen SARS-CoV-2-positive athletes to safely resume training and competitions. The aim of this study is to understand which investigations are useful in a screening protocol aimed at protecting health but also avoiding inappropriate examinations.

Methods: We conducted a cohort study of a professional soccer team that is based on an extensive screening protocol for resuming training during the COVID-19 pandemic. It included personal history, antigen swabs, blood tests, spirometry, resting/stress-test ECG with oxygen saturation monitoring, echocardiogram, Holter and chest CT. We also compared the findings with prior data from the same subjects before infection and with data from SARS-CoV-2-negative players.

Results: None of the players had positive swab and/or anti-SARS-CoV-2 IgM class antibodies. Out of 30 players, 18 (60%) had IgG class antibodies. None had suffered severe SARS-CoV-2-related disease, 12 (66.7%) had complained of mild COVID-19-related symptoms and 6 (33.3%) were asymptomatic. None of the players we examined revealed significant cardiovascular abnormalities after clinical recovery. A mild reduction in spirometry parameters versus pre-COVID-19 values was observed in all athletes, but it was statistically significant (p<0.05) only in SARS-CoV-2-positive athletes. One SARS-CoV-2-positive player showed increased troponin I level, but extensive investigation did not show signs of myocardial damage.

Conclusion: In this small cohort of athletes with previous asymptomatic/mild SARS-CoV-2 infection, a comprehensive screening protocol including blood tests, spirometry, resting ECG, stress-test ECG with oxygen saturation monitoring and echocardiogram did not identify relevant anomalies. While larger studies are needed, extensive cardiorespiratory and haematological screening in athletes with asymptomatic/mild SARS-CoV-2 infection appears unnecessary.

Keywords: athlete; exercise testing; heart disease; prevention; soccer.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Instrumental findings in a player with increased troponin I level. In the only SARS-CoV-2-positive player (asymptomatic) with increased troponin I level, resting (A) and stress-test (B) ECG were normal. Chest CT at the level of the plane passing through the upper right lobar bronchus (C) and of the plane passing through lung bases (D) was absolutely normal. (E–M) Cardiac magnetic resonance images acquired using a 1.5 T Siemens Aera (Siemens Healthcare, Erlangen, Germany). (E) Short-axis cine balanced steady-state free precession showed normal left ventricle end-diastolic volume, wall thickness and motion. (F) Short-axis T2 image showed no oedema. (G, H) Short-axis and four-chamber views showed no alteration of late gadolinium enhancement. (I, J) Short-axis T1 native and T1 postcontrast maps showed normal values of T1 and extracellular volume. (K) T2 map showed no oedema.

References

    1. Phelan D, Kim JH, Chung EH. A game plan for the resumption of sport and exercise after coronavirus disease 2019 (COVID-19) infection. JAMA Cardiol 2020. 10.1001/jamacardio.2020.2136. [Epub ahead of print: 13 May 2020]. - DOI - PubMed
    1. Baggish A, Drezner JA, Kim J, et al. Resurgence of sport in the wake of COVID-19: cardiac considerations in competitive athletes. Br J Sports Med 2020;54:1130–1. 10.1136/bjsports-2020-102516 - DOI - PMC - PubMed
    1. Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol 2020;75:2352–71. 10.1016/j.jacc.2020.03.031 - DOI - PMC - PubMed
    1. Long B, Brady WJ, Koyfman A, et al. Cardiovascular complications in COVID-19. Am J Emerg Med 2020;38:1504–7. 10.1016/j.ajem.2020.04.048 - DOI - PMC - PubMed
    1. Vessella T, Zorzi A, Merlo L, et al. The Italian preparticipation evaluation programme: diagnostic yield, rate of disqualification and cost analysis. Br J Sports Med 2020;54:231–7. 10.1136/bjsports-2018-100293 - DOI - PMC - PubMed